Whole Shine Medical Technology Co., Ltd. Class A

As of June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A carries a market capitalization of 1.74B, placing it among publicly traded companies globally. Its enterprise value stands at 2.09B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A has 840.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A maintains a current ratio of 0.29, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A recorded 4.17M in income tax expense.

As of the close on October 23, 2026, Whole Shine Medical Technology Co., Ltd. Class A's stock has declined approximately 32.23% over the past 52 weeks. The 50-day moving average sits at 2.52, while the 200-day moving average is 2.62.

As of June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A holds 138.90M in cash and equivalents against 439.78M in total debt, resulting in a net debt position of 51.98M. Total book value stands at 260.96M, with working capital of -631.06M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Whole Shine Medical Technology Co., Ltd. Class A paid dividends of 0.01 per share.

Whole Shine Medical Technology Co., Ltd. Class A's most recent stock split took place on May 19, 2016 with a 1:2 split ratio.